IBRX icon

ImmunityBio

61 hedge funds and large institutions have $9.95M invested in ImmunityBio in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

2.76% less ownership

Funds ownership: 13.59%10.83% (-2.8%)

75% less capital invested

Capital invested by funds: $39.8M → $9.95M (-$29.9M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48K
Puts
$38K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.02M
2
$1.43M
3
$1.25M
4
$645K
5
$477K
6
$381K
7
$329K
8
$300K
9
$292K
10
$270K
11
$266K
12
$210K
13
$210K
14
$172K
15
$156K
16
$137K
17
$132K
18
$117K
19
$92K
20
$84K
21
$76K
22
$64K
23
$60K
24
$57K
25
$56K